Understanding the evolving CAR-T marketIn August 2017, Novartis made history after receiving FDA approval for Kymriah, the world’s first chimeric antigen receptor Share XUnderstanding the evolving CAR-T markethttps://pharmaphorum.com/partner-content/understanding-the-evolving-car-t-market/
Available on-demand: COPD, connecting real world needs to patient centric solutions COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and Share XAvailable on-demand: COPD, connecting real world needs to patient centric solutionshttps://pharmaphorum.com/debates-insight-patients/live-webinar-debate-feb-4th-copd-connecting-real-world-needs-to-patient-centric-solutions-price-is-right-uk-niche-market-access-2/
